MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer
Open Access
- 7 November 2008
- journal article
- retraction
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 283 (45), 31079-31087
- https://doi.org/10.1074/jbc.m806041200
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- MicroRNAs 221 and 222 Bypass Quiescence and Compromise Cell SurvivalCancer Research, 2008
- DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell linesMolecular Cancer, 2008
- Endogenous human microRNAs that suppress breast cancer metastasisNature, 2008
- Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell lineMolecular Cancer, 2008
- An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferationThe EMBO Journal, 2007
- The Micro-Ribonucleic Acid (miRNA) miR-206 Targets the Human Estrogen Receptor-α (ERα) and Represses ERα Messenger RNA and Protein Expression in Breast Cancer Cell LinesMolecular Endocrinology, 2007
- Estrogen receptor alpha (ERα) mRNA copy numbers in immunohistochemically ERα-positive-, and negative breast cancer tissuesBMC Cancer, 2007
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colonNature Genetics, 1994